Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Mounjaro KwikPen 5mg/0.6ml inj 2.4ml pre-filled pens
0601023AZBBAGAG
|
Mounjaro | Tirzepatide | Endocrine System | 105,198 |
|
Mounjaro KwikPen 2.5mg/0.6ml inj 2.4ml pre-filled pens
0601023AZBBAHAH
|
Mounjaro | Tirzepatide | Endocrine System | 51,586 |
|
Mounjaro KwikPen 7.5mg/0.6ml inj 2.4ml pre-filled pens
0601023AZBBACAC
|
Mounjaro | Tirzepatide | Endocrine System | 24,708 |
|
Mounjaro KwikPen 10mg/0.6ml inj 2.4ml pre-filled pens
0601023AZBBAFAF
|
Mounjaro | Tirzepatide | Endocrine System | 10,826 |
|
Mounjaro KwikPen 12.5mg/0.6ml inj 2.4ml pre-filled pens
0601023AZBBAEAE
|
Mounjaro | Tirzepatide | Endocrine System | 2,198 |
|
Mounjaro KwikPen 15mg/0.6ml inj 2.4ml pre-filled pens
0601023AZBBADAD
|
Mounjaro | Tirzepatide | Endocrine System | 1,993 |
|
Mounjaro 2.5mg/0.5ml solution for injection pre-filled pens
0601023AZBBAAAA
|
Mounjaro | Tirzepatide | Endocrine System | 88 |
|
Mounjaro 5mg/0.5ml solution for injection pre-filled pens
0601023AZBBABAB
|
Mounjaro | Tirzepatide | Endocrine System | 52 |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.